Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: The implementation of the 2017 national policy on patient-reported outcomes in Denmark: An overview of developments after six years

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Egholm et al. investigated the implementation of a national patient-reported outcomes (PRO) policy in Denmark which aims to enhance patient-centered approaches in healthcare and realize benefits at the individual patient level. The paper outlines the three key elements: developing standardized PRO instruments within specific clinical areas, establishing a PRO instrument repository, and creating a national IT infrastructure for data sharing. Furthermore, the authors provided an overview of the progress made after six years of implementation, highlighting the promising value of PRO instruments for both patients and healthcare professionals, as well as challenges in operationalizing the IT infrastructure and implementation across healthcare sectors.

Access the full-text article here.